Key result
US diabetes and hematological mortality climbs, peaking with an ~18% annual surge from 2018 to 2020.
Why the study?
Diabetes mellitus and hematological disorders pose substantial, intersecting health challenges in the US, but long-term national mortality trends were uncharacterized.
Observational (n=217,168)
Yes
Mortality attributed to diabetes and hematological disorders in the US increased significantly from 1999 to 2020, with a sharp rise between 2018 and 2020 and notable geographic and demographic disparities.
Answers are grounded in this paper and cite their sources.
Comorbid diabetes and hematological disorders warrant clinical vigilance; this observational study leaves open modifiable risk factors and intervention targets.
Introduction and Objective: Diabetes mellitus (DM) and hematological disorders pose substantial and intersecting health challenges in the US. DM affects 38.4 million people (11.6%), while anemia and blood cancers impact 9.3% and 1.7 million individuals, respectively. This study looks at trends in HD and DM mortality in the US from 1999 to 2020. Methods: This study analyzed CDC WONDER data to assess age-adjusted mortality rates (AAMR) per 100,000 for DM (ICD-10: E08-E13) and HD (D50-D89) as contributing causes of death. Annual percent changes (APCs) across demographic and geographic subgroups were calculated using Joinpoint regression (Version 5.1.0, National Cancer Institute). Results: From 1999 to 2020, 217,168 deaths were attributed to hematological disorders (HD) and diabetes mellitus (DM) in the U.S. AAMR rose significantly, with an initial increase (APC 2.95, 1999-2006), a slight decline (APC -0.73, 2006-2018), and a sharp rise (APC 18.20, 2018-2020). Males had a higher AAPC (2.69) than females (1.65). Regionally, the West (2.61) and South (2.65) showed the steepest increases. Whites (2.30) and Asian/Pacific Islanders (1.56) had the highest racial AAPCs. Non-metropolitan areas had higher AAMRs than metropolitan ones (35.09 vs. 28.26). Among states, Hawaii (71.25), Texas (66.19), and Washington (59.42) had the highest AAMRs. Hispanic deaths totaled 21,990. Most deaths occurred in medical facilities (41.45%) and long-term care settings (24.96%). Conclusion: From 1999- 2000, mortality for HD and DM significantly increased in the U.S. Males, Whites, Asians, the West region, and non-metropolitan areas.
No takes yet. Share an insight, caveat, or question.
Saeed et al. (2026) conducted an observational in Diabetes mellitus and hematological disorders (n=217,168). Time period (1999-2020) and demographic/geographic factors was evaluated on Age-adjusted mortality rates (AAMR) per 100,000 for DM and HD as contributing causes of death. Between 1999 and 2020, US mortality rates for diabetes and hematological disorders increased significantly, with the sharpest rise occurring from 2018 to 2020.
Synapse has enriched 10 related papers. Consider them for comparative context: